Allergan Aesthetics Celebrates the Second Annual JUVÉDERM® Day
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the return of JUVÉDERM® Day on August 21, 2024. This second annual event offers exclusive deals and savings through the Allē loyalty program. Highlights include:
1. BOGO Gift Cards: Members can purchase a $75 JUVÉDERM® gift card and receive an additional $75 card free.
2. Allē Flash: Schedule a consultation for a chance to save up to $500 on JUVÉDERM® treatment.
3. Sweepstakes: Get treated by September 30 for a chance to win $10,000.
JUVÉDERM® remains the top chosen hyaluronic acid dermal filler collection globally. The event aims to surpass last year's record-breaking treatment numbers and drive consumers to practices. Allē, serving over 7 million members across ~30,000 practices, offers rewards on various aesthetic treatments and flexible payment plans.
Allergan Aesthetics, un'azienda di AbbVie (NYSE: ABBV), annuncia il ritorno del JUVÉDERM® Day il 21 agosto 2024. Questo secondo evento annuale offre offerte esclusive e risparmi attraverso il programma fedeltà Allē. I punti salienti includono:
1. Gift Card BOGO: I membri possono acquistare una gift card da $75 per JUVÉDERM® e ricevere un'ulteriore card da $75 gratuitamente.
2. Allē Flash: Prenota una consultazione per avere la possibilità di risparmiare fino a $500 sul trattamento JUVÉDERM®.
3. Estrazione: Ricevi un trattamento entro il 30 settembre per avere la possibilità di vincere $10.000.
JUVÉDERM® rimane la collezione di filler dermici a base di acido ialuronico più scelta a livello globale. L'evento mira a superare i numeri record dei trattamenti dello scorso anno e a stimolare i consumatori ad avvicinarsi ai centri estetici. Allē, con oltre 7 milioni di membri in circa 30.000 centri, offre premi su vari trattamenti estetici e piani di pagamento flessibili.
Allergan Aesthetics, una empresa de AbbVie (NYSE: ABBV), anuncia el regreso del Día JUVÉDERM® el 21 de agosto de 2024. Este segundo evento anual ofrece ofertas exclusivas y ahorros a través del programa de lealtad Allē. Los aspectos destacados incluyen:
1. Tarjetas de regalo BOGO: Los miembros pueden comprar una tarjeta de regalo de JUVÉDERM® de $75 y recibir una tarjeta adicional de $75 gratis.
2. Allē Flash: Programa una consulta para tener la oportunidad de ahorrar hasta $500 en el tratamiento JUVÉDERM®.
3. Sorteo: Recibe tratamiento antes del 30 de septiembre para tener la oportunidad de ganar $10,000.
JUVÉDERM® sigue siendo la colección de rellenos dérmicos de ácido hialurónico más elegida a nivel mundial. El evento tiene como objetivo superar los números récord de tratamientos del año pasado y atraer a los consumidores a los centros de estética. Allē, con más de 7 millones de miembros en aproximadamente 30,000 prácticas, ofrece recompensas en varios tratamientos estéticos y planes de pago flexibles.
알레르간 미용, AbbVie(뉴욕증권거래소: ABBV) 소속, 2024년 8월 21일에 JUVÉDERM® 데이의 귀환을 발표했습니다. 두 번째 연례 행사는 Allē 로열티 프로그램을 통해 독점 할인 및 절약 혜택을 제공합니다. 주요 내용은 다음과 같습니다:
1. BOGO 기프트 카드: 회원은 $75 JUVÉDERM® 기프트 카드를 구매하고 추가로 $75 카드를 무료로 받습니다.
2. Allē Flash: 상담을 예약하고 JUVÉDERM® 치료에 대해 최대 $500을 절약할 기회를 얻으세요.
3. 추첨: 9월 30일까지 치료를 받으면 $10,000을 받을 기회가 있습니다.
JUVÉDERM®은 전 세계적으로 가장 많이 선택되는 히알루론산 필러 컬렉션입니다. 이번 행사는 작년의 기록을 넘는 치료 수치를 목표로 하며 소비자들을 시술소로 유도합니다. Allē는 약 30,000개의 의료기관에서 700만 명 이상의 회원에게 다양한 미용 치료와 유연한 결제 계획에 대한 보상을 제공합니다.
Allergan Aesthetics, une société d'AbbVie (NYSE: ABBV), annonce le retour du JUVÉDERM® Day le 21 août 2024. Ce deuxième événement annuel offre des offres exclusives et des économies via le programme de fidélité Allē. Les points forts comprennent :
1. Cartes-cadeaux BOGO : Les membres peuvent acheter une carte-cadeau JUVÉDERM® de 75 $ et recevoir une carte supplémentaire de 75 $ gratuitement.
2. Allē Flash : Prenez rendez-vous pour tenter d'économiser jusqu'à 500 $ sur un traitement JUVÉDERM®.
3. Tirage au sort : Recevez un traitement avant le 30 septembre pour avoir la chance de gagner 10 000 $.
JUVÉDERM® reste la collection de produits de comblement dermique à base d'acide hyaluronique la plus choisie au niveau mondial. L'événement vise à dépasser les chiffres records de traitements de l'année dernière et à inciter les consommateurs à se rendre dans les établissements. Allē, qui compte plus de 7 millions de membres dans environ 30 000 pratiques, propose des récompenses sur divers traitements esthétiques et des plans de paiement flexibles.
Allergan Aesthetics, ein Unternehmen von AbbVie (NYSE: ABBV), kündigt die Rückkehr des JUVÉDERM® Days am 21. August 2024 an. Diese zweite jährliche Veranstaltung bietet exklusive Angebote und Einsparungen über das Allē Treueprogramm. Zu den Höhepunkten gehören:
1. BOGO Geschenkkarten: Mitglieder können eine JUVÉDERM® Geschenkkarte im Wert von 75 $ kaufen und eine zusätzliche Karte im Wert von 75 $ kostenlos erhalten.
2. Allē Flash: Vereinbaren Sie einen Beratungstermin, um die Chance zu nutzen, bis zu 500 $ auf eine JUVÉDERM® Behandlung zu sparen.
3. Verlosung: Lassen Sie sich bis zum 30. September behandeln für die Chance, 10.000 $ zu gewinnen.
JUVÉDERM® bleibt die weltweit am häufigsten gewählte Sammlung von dermalen Füllstoffen auf Hyaluronsäurebasis. Die Veranstaltung soll die Rekordzahl der Behandlungen des letzten Jahres übertreffen und Verbraucher in die Praxen bringen. Allē bedient über 7 Millionen Mitglieder in rund 30.000 Praxen und bietet Belohnungen für verschiedene ästhetische Behandlungen sowie flexible Zahlungspläne.
- None.
- None.
- Join the seven million loyal Allē Members in celebrating the second annual JUVÉDERM® Day on August 21, 2024
- Members receive an exclusive gift card offer and a chance to win
$10,000
"JUVÉDERM® Day 2023 logged the most treatments in a single day for the brand, and our goal is to surpass that this year. During this year's event, we are providing even more exclusive offers to drive consumers into practices," said Jasson Gilmore, Senior Vice President
More than 18 million consumers are interested in receiving treatment with dermal filler, and JUVÉDERM® offers a robust collection of products specifically designed to address consumers' top aesthetic concerns. JUVÉDERM® remains the number one chosen hyaluronic acid (HA) dermal filler collection on the market and is trusted by providers globally1.
Consumers eager to try treatment and participate in JUVÉDERM® Day are encouraged to join Allē at alle.com/registration to receive exclusive offers, including:
- BOGO Gift Cards†: On Wednesday, August 21 starting at 9 a.m. Pacific Time, Allē Members who purchase a
$75 $75 - Book a Consultation, Save with Allē Flash: Schedule a consultation with a participating Allē provider between August 21 and September 30, and check in with Allē Flash for a chance to instantly save up to
$500 - JUVÉDERM® Day Sweepstakes: Get treated by September 30 and enter the JUVÉDERM® Day Sweepstakes for a chance to win
$10,000
"As we continue to see consumer trends shift towards a more natural-looking aesthetic, my patients are coming to me specifically looking for subtle treatment outcomes, and I trust the JUVÉDERM® Collection of Fillers to help me deliver the results they desire," said Dr. Deborah Sherman, Board-certified ophthalmologist, Fellowship-trained Oculofacial Plastic Surgeon, and founder of Sherman Aesthetic Center in
JUVÉDERM® Day is recognized by National Day Archives as an official holiday on the National Day Registry™, JUVÉDERM® Day will be held annually on the third Wednesday of August. For more information on the JUVÉDERM® Collection of Fillers, visit Juvederm.com and follow @JUVEDERM on Instagram and TikTok.
In serving more than seven million Members across ~30,000 practices to date, part of Allē's mission is to help educate consumers about aesthetic treatments, and to simplify office operations for practices. From its inception, Allē has disrupted the aesthetics industry by offering the most robust rewards program. Allē is the first and only loyalty program in the aesthetics market to also offer consumers the ability to earn points on over 50 non-Allergan Aesthetics treatments and brands. By providing Members with information, tools, and incentives, and now with flexible ways to pay though Allē Payment Plans, Allē empowers consumers along their treatment journey, making the next product purchase or treatment closer within reach.
*NO PURCHASE NECESSARY TO ENTER TO WIN. Open to Allē Members in 50 U.S./D.C.; 18+ (19+ in AL, NE, 21+ in MS) Void where prohibited. Registration starts 08/21/2024. See full Official Rules for all details and how to enter without purchase at
https://alle.com/lp/juvdaysweeps-official-rules.
†Gift cards can be used exclusively towards treatment with any product in the JUVÉDERM® Collection of Fillers. SKINVIVE by JUVÉDERM® is excluded from all promotions.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
JUVÉDERM® Injectable Gel Fillers Important Information
APPROVED USES
JUVÉDERM® VOLUX® XC injectable gel is for deep injection to improve moderate to severe loss of jawline definition in adults over the age of 212.
JUVÉDERM® VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to improve the chin profile in adults over 213.
JUVÉDERM® VOLLURE® XC, JUVÉDERM® Ultra Plus XC, and JUVÉDERM® Ultra XC injectable gels are for injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds 4–6. JUVÉDERM® VOLLURE® XC injectable gel is for adults over 214.
JUVÉDERM® Ultra XC injectable gel is also for injection into the lips and perioral area for lip augmentation in adults over 215.
JUVÉDERM® VOLBELLA® XC injectable gel is for injection into the lips for lip augmentation and correction of perioral lines, and for injection into the undereye hollows to improve the appearance of undereye hollows in adults over the age of 217.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive any JUVÉDERM® formulation?
Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), if you are allergic to lidocaine or the Gram-positive bacterial proteins used in these products, or if you have had previous allergic reactions to hyaluronic acid fillers.
What warnings should my doctor advise me about?
- One of the risks with using dermal fillers is the unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. Most of these events are irreversible.
- If you have changes in your vision, signs of a stroke (including sudden difficulty speaking, numbness or weakness in your face, arms or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion), white appearance of the skin, or unusual pain during or shortly after treatment, you should notify your health care practitioner immediately.
- The use of dermal fillers where skin sores, pimples, rashes, hives, cysts, or infections are present should be postponed, as this may delay healing or make skin problems worse.
- The effectiveness of removal of any dermal filler has not been studied.
What precautions should my doctor advise me about?
- JUVÉDERM® VOLBELLA® XC should only be injected into undereye hollows by doctors who have completed the necessary training for this treatment area. To find a doctor, visit Juvederm.com/find-a-specialist. Doctors who complete the training will be listed with a symbol
- The safety of these products for use during pregnancy or while breastfeeding has not been studied
- The safety of JUVÉDERM® VOLUMA® XC has not been studied in patients under 35 years or over 65 years for cheek augmentation, or under 22 years and over 80 years for chin augmentation. The safety of JUVÉDERM® VOLUX® XC, JUVÉDERM® VOLLURE® XC and JUVÉDERM® VOLBELLA® XC has not been studied in patients under 22 years, and the safety of JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC has not been studied in patients under 18 years
- The safety and effectiveness of treatment with JUVÉDERM® products in anatomical regions outside of their approved uses have not been established in clinical studies
- If you have a history of excessive scarring (thick, hard scars) or pigmentation disorders, treatment in these patients has not been studied and may result in additional scars or changes in pigmentation
- If you are planning other procedures including laser treatments or a chemical peel, there is a possible risk of inflammation at the treatment site if these procedures are performed closely before or after JUVÉDERM® injectable gel treatment
- Tell your doctor if you are on therapy used to reduce your body's natural defense system (such as steroids, chemotherapy, and medicines to treat autoimmune diseases, HIV, and AIDs), as these may increase your risk of infection; and medications that can prolong bleeding (such as aspirin, ibuprofen, or other blood thinners), as these may result in increased bruising or bleeding at the injection site.
- Avoid applying makeup for 12 hours after treatment and minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment, as these may cause temporary redness, swelling, and/or itching at the injection site
- JUVÉDERM® VOLUMA® XC was not studied in patients with significant loose skin of the chin, neck, or jaw
- The effect of JUVÉDERM® VOLUMA® XC injection into the chin on facial hair growth has not been studied
- Patients who experience skin injury near the site of JUVÉDERM® VOLUMA® XC injection may be at a higher risk for adverse events
- Tell your doctor if you have already been injected with dermal fillers in the same area as the one(s) you are about to be treated for. This information helps your doctor decide when and whether you should get treatment
What are possible side effects of treatment?
The most commonly reported side effects with JUVÉDERM® injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM® VOLBELLA® XC, dryness was also reported.
These side effects are consistent with other facial injection procedures and most will resolve within 30 days. Your doctor may choose to treat side effects persisting longer with antibiotics, steroids, or hyaluronidase (an enzyme that breaks down hyaluronic acid).
As with all skin injection procedures, there is a risk of infection.
To report a side effect with any product in the JUVÉDERM® Collection, please call the Allergan® Product Support Department at 1‑877‑345‑5372. Please also visit Juvederm.com or talk to your doctor for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician or properly licensed practitioner.
References:
- Data on File, Allergan; Dermal Filler AMT, November 2023.
- JUVÉDERM® VOLUX® XC Directions for Use, 2023.
- JUVÉDERM® VOLUMA® XC Directions for Use, 2023.
- JUVÉDERM® VOLLURE® XC Directions for Use, 2023.
- JUVÉDERM® Ultra XC Directions for Use, 2023.
- JUVÉDERM® Ultra Plus XC Directions for Use, 2023.
- JUVÉDERM® VOLBELLA® XC Directions for Use, 2023.
© 2024 AbbVie. All rights reserved. JUVÉDERM and its designs are trademarks of Allergan Holdings France SAS, and AbbVie company, or its affiliates. All other trademarks are property of their respective owners.
View original content:https://www.prnewswire.com/news-releases/allergan-aesthetics-celebrates-the-second-annual-juvederm-day-302209123.html
SOURCE AbbVie
FAQ
When is JUVÉDERM® Day 2024 and what does it offer?
How can I participate in JUVÉDERM® Day 2024 offers?
What is the market position of JUVÉDERM® in the dermal filler industry?
How many members does the Allē loyalty program have?
What unique features does the Allē loyalty program offer?
